Australia, August 26 - Patients with long COVID experience functional deterioration and significant losses in quality of life at levels similar to those observed after a stroke or diseases such as rheumatoid arthritis and Parkinson’s, according to authors of a new study from Deakin University.
The World Health Organization (WHO) defines this condition as the persistence or emergence of various symptoms three months after SARS-CoV-2 infection, with symptoms lasting at least two months without any other explanation.
This illness can significantly affect the quality of life of those who suffer from it as they struggle with fatigue, difficulty breathing, mental confusion, dizziness, pain, palpitations, and other symptoms that limit their ability to socialize, perform household tasks, and work for months or even years, revealed a study published this Monday in the Australian Journal of Primary Health.
Although the risk is lower than at the start of the pandemic, around 6% of those who had COVID-19 could develop this condition, with women, older adults, smokers, individuals with obesity, and those with chronic illnesses being more vulnerable.
The study involved 121 Australian adults aged between 36 and 50 who experienced long COVID from 2020 to 2022. Participants completed the WHO Disability Assessment Scale to measure disability and functionality, as well as the Short Form Health Survey to evaluate everyday quality of life. (Text and Photo: Cubasí) Patients with long COVID experience functional deterioration and significant losses in quality of life at levels similar to those observed after a stroke or diseases such as rheumatoid arthritis and Parkinson’s, according to authors of a new study from Deakin University.
The World Health Organization (WHO) defines this condition as the persistence or emergence of various symptoms three months after SARS-CoV-2 infection, with symptoms lasting at least two months without any other explanation.
This illness can significantly affect the quality of life of those who suffer from it as they struggle with fatigue, difficulty breathing, mental confusion, dizziness, pain, palpitations, and other symptoms that limit their ability to socialize, perform household tasks, and work for months or even years, revealed a study published this Monday in the Australian Journal of Primary Health.
Although the risk is lower than at the start of the pandemic, around 6% of those who had COVID-19 could develop this condition, with women, older adults, smokers, individuals with obesity, and those with chronic illnesses being more vulnerable.
The study involved 121 Australian adults aged between 36 and 50 who experienced long COVID from 2020 to 2022. Participants completed the WHO Disability Assessment Scale to measure disability and functionality, as well as the Short Form Health Survey to evaluate everyday quality of life. (Text and photo: Cubasí)